Your browser doesn't support javascript.
loading
Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti-CD40 Antibody, in Patients With Active Lupus Nephritis: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.
Jayne, David R; Steffgen, Jürgen; Romero-Diaz, Juanita; Bajema, Ingeborg; Boumpas, Dimitrios T; Noppakun, Kajohnsak; Amano, Hirofumi; Gomez, Harold Michael; Satirapoj, Bancha; Avihingsanon, Yingyos; Chawanasuntorapoj, Ratana; Madero, Magdalena; Naumnik, Beata; Recto, Rhona; Fagan, Nora; Revollo, Ivette; Wu, Jing; Visvanathan, Sudha; Furie, Richard.
Afiliación
  • Jayne DR; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Steffgen J; Boehringer Ingelheim International GmbH, Biberach, Germany.
  • Romero-Diaz J; Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubiran", Mexico City, Mexico.
  • Bajema I; Department of Pathology and Medical Biology, University of Groningen, University Medical Center, Groningen, the Netherlands.
  • Boumpas DT; Department of Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Noppakun K; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Amano H; Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.
  • Gomez HM; Angeles University Foundation Medical Center, Angeles City, Philippines.
  • Satirapoj B; Division of Nephrology, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
  • Avihingsanon Y; Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Chawanasuntorapoj R; Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Madero M; National Institute of Cardiology Ignacio Chávez, Mexico City, Mexico.
  • Naumnik B; Department of Nephrology and Transplantation with Dialysis Unit, Medical University of Bialystok, Bialystok, Poland.
  • Recto R; Mary Mediatrix Medical Center, Lipa City, Philippines.
  • Fagan N; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut.
  • Revollo I; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
  • Wu J; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut.
  • Visvanathan S; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut.
  • Furie R; Northwell Health and Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York.
Arthritis Rheumatol ; 75(11): 1983-1993, 2023 11.
Article en En | MEDLINE | ID: mdl-37192040
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nefritis Lúpica Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Arthritis Rheumatol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nefritis Lúpica Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Arthritis Rheumatol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos